Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Hikal gets Brazilian GMP certification and US FDA EIR for Bangalore and Panoli facilities
Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a…
Parexel, Partex announce alliance to leverage AI, Big Data to accelerate drug discovery and…
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better…
Venus Remedies launches its flagship R&D drug Elores in Oman
The antibacterial market in Oman is worth $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Glenmark gets ANDA approval for Tacrolimus Ointment, 0.03%
Glenmark’s Tacrolimus Ointment, 0.03%, will be distributed in the US by Glenmark Pharmaceuticals, US
Lupin gets US FDA nod for Bromfenac Ophthalmic Solution, 0.09%; Metoprolol Succinate ER Tablets USP
Both products will be manufactured at Lupin’s Pithampur facility in India
Delayed payments to pharma MSMEs: A major challenge
Delayed payments put SMEs at a disadvantage compared to large size counterparts, inhibiting their ability to compete effectively…
Lupin gets US FDA approval for Doxycycline Hyclate Delayed-Release Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India
Our collaborations with Govt of India focus on building resilient healthcare systems
Sylvia Varela, AVP Asia Area, AstraZeneca discusses about the company’s plans to drive market growth, address public health…
Novo Nordisk to acquire Inversago Pharma for up to $1.075 bn
The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist
Sigachi Industries forays into API business, acquires majority stake in Trimax Bio Sciences
The API unit is approved by USFDA for advanced and critical intermediates
Dr Reddy’s Laboratories launch Saxagliptin and Metformin Hydrochloride ER tablets in US
Saxagliptin and metformin hydrochloride ER tablets are indicated as an adjunct to diet and exercise to improve glycemic control in…
UPS Healthcare launches UPS Premier service across India
Indian customers will have access to UPS Premier Gold service benefits, including “first-in, first-off” prioritisation, built-in…
Boehringer Ingelheim launches NexGard (afoxolaner) Small and Medium in India
NexGard is indicated for use in dogs and puppies from eight weeks of age and is delivered as a monthly treatment in highly…
NASH market holds enormous untapped potential: GlobalData
Currently, Madrigal’s resmetirom (selective thyroid hormone receptor-β agonist; THR-Beta agonist) will most likely be the first…
CEPI to support development of selfamplifying mRNA vaccine technology for use against Disease X
CEPI will provide up to $3.6 million to support the optimisation of the saRNA-platform technology, the production process, and…
Dyslipidemia market to grow to $15.53 bn in 2032 across 7MM: GlobalData
Growth will be driven by the launch of therapies with promising efficacies and new mechanism of actions, as well as the growth of…
WHO flags Cold Out cough syrup over higher limits of diethylene and ethylene glycol
The batch had 0.25 per cent of diethylene glycol and 2.1 per cent of ethylene glycol, when the acceptable safety limit for both is…
Marksans announces completion US FDA PADE inspection
The inspection was conducted at its Goa, Verna manufacturing facility from July 31, 2023 to August 4, 2023
Daiichi Sankyo will remain dominant in ADC market for oncology treatments: GlobalData
By 2029, the global market for ADC therapies in oncology is expected to be worth more than $36 billion